• Canadian Critical Care Trials Group
    The Canadian Critical Care Trials Group (CCCTG) is a highly collegial group that is dedicated to the pursuit of excellence and advancement of critical care research in Canada.
  • Canadian Critical Care Trials Group
    The CCCTG has are more than 30 research programs underway and over 100 peer-reviewed publications to its credit, with direct impact on clinical practice in critical care.
  • Canadian Critical Care Trials Group
    The Canadian Critical Care Trials Group (CCCTG) is a national organization of more than 300 individuals with research interests in the management of the critically ill patient.
  • Canadian Critical Care Trials Group
    Endorsement by the CCCTG communicates our full commitment to ensure that the work is undertaken in a rigorous and ethical manner, and communicated in a timely and effective way.
Coordinates

Institution

CHU de Québec - Université Laval (Hôpital de l'Enfant-Jésus)

City

Québec

Contact This Member

Alexis F. Turgeon

Alexis Turgeon is an Assistant Professor in the Division of Critical Care Medicine and the Department of Anesthesiology, at Université Laval. He is the Director of Research for the Division of Critical Care Medicine and for the Department of Anesthesiology.

Alexis F. Turgeon practices Critical Care Medicine and Anesthesia at the CHU de Québec - Hôpital de l’Enfant-Jésus (Enfant-Jésus Hospital) in Québec City. He is the co-chair of the Grants and Manuscripts Committee of the CCCTG. Alexis Turgeon first graduated from Université Laval medical school in 1999 and, following residency training in Anesthesiology, he completed a master’s degree in Clinical Epidemiology. He pursued training in Critical Care Medicine at the University of Ottawa along with a research fellowship at the Clinical Epidemiology Unit of the Ottawa Hospital Research Institute. He is a clinician-scientist in the Traumatology – Emergency – Critical Care Medicine Unit (Trauma – Urgence – Soins Intensifs) at the Centre de Recherche du CHU de Québec.

Alexis Turgeon’s research program focuses on the evaluation of the neurological prognosis in critically ill patients with severe traumatic brain injury and on the comprehension of level of care decisions in neurocritically ill patients. As part of his research program and with colleagues from across Canada, he recently showed a variation in mortality in patients with severe traumatic brain injury across centers in Canada, and a variation in the incidence of withdrawal of life-sustaining therapies.

He currently leads the CIHR-funded TBI-Prognosis Multicenter Prospective Study, a pan-canadian study aiming to develop a prognostic model of long-term prognosis following severe traumatic brain injury. He also leads the FRQ-S-funded TBI-QualE Study aiming to understand the determinants of the decision to withdraw life-sustaining therapies in critically ill patients with traumatic brain injury. Alexis Turgeon his also involved in the use of blood products in critically ill patients, and has a strong methodological interest in systematic reviews and meta-analyses.